Zobrazeno 1 - 8
of 8
pro vyhledávání: '"van Dijken, Joke H."'
Autor:
van Dijken, Joke H., Veldstra, J.L., van de Loo, A.J.A.E., Verster, J.C., van der Sluiszen, Nick N.J.J.M., Vermeeren, Annemiek, Ramaekers, J. G., Brookhuis, Karel A, de Waard, Dick, Afd Pharmacology, dIRAS RA-1, Pharmacology
Publikováno v:
Transportation Research Part F: Traffic Psychology and Behaviour, 73, 119. Elsevier Limited
Transportation Research Part F-Traffic Psychology and Behaviour, 73, 119-127. ELSEVIER SCI LTD
Transportation Research. Part F: Traffic Psychology and Behaviour, 73, 119-127. ELSEVIER SCI LTD
Transportation Research Part F-Traffic Psychology and Behaviour, 73, 119-127. ELSEVIER SCI LTD
Transportation Research. Part F: Traffic Psychology and Behaviour, 73, 119-127. ELSEVIER SCI LTD
Objective: The influence of psychoactive substances on driving performance and traffic safety has been extensively studied. Research on the influence of alcohol at the control level of behaviour (i.e. automated processes) has been well established an
Autor:
Vinckenbosch, Frederick R J, Vermeeren, Annemiek, Vuurman, Eric F P M, van der Sluiszen, Nick N J J M, Verster, Joris C, van de Loo, Aurora J A E, van Dijken, Joke H, Veldstra, Janet L, Brookhuis, Karel A, De Waard, Dick, Ramaekers, Johannes G, Afd Pharmacology, dIRAS RA-1, Pharmacology
Publikováno v:
Human Psychopharmacology-Clinical and Experimental, 36(4):e2778, 1-17. Wiley
Human Psychopharmacology, 36(4):e2778. John Wiley and Sons Ltd
Human Psychopharmacology, 36(4). John Wiley and Sons Ltd
Human Psychopharmacology
Human Psychopharmacology, 36(4):e2778. John Wiley and Sons Ltd
Human Psychopharmacology, 36(4). John Wiley and Sons Ltd
Human Psychopharmacology
Objective: Previous research reported cognitive and psychomotor impairments in long‐term users of benzodiazepine receptor agonists (BZRAs). This article explores the role of acute intoxication and clinical complaints.Methods: Neurocognitive and on
Autor:
van der Sluiszen, Nick N J J M, Vermeeren, Annemiek, van Dijken, Joke H, J A E van de Loo, Aurora, Veldstra, Janet L, de Waard, Dick, C Verster, Joris, A Brookhuis, Karel, Ramaekers, Johannes G, Afd Pharmacology, dIRAS RA-1, Pharmacology
Publikováno v:
Human Psychopharmacology-Clinical and Experimental, 36(1):e2762. Wiley
Human Psychopharmacology
Human Psychopharmacology, 36(1), 1. John Wiley and Sons Ltd
Human Psychopharmacology, 36(1):2762. John Wiley and Sons Ltd
Human Psychopharmacology
Human Psychopharmacology, 36(1), 1. John Wiley and Sons Ltd
Human Psychopharmacology, 36(1):2762. John Wiley and Sons Ltd
Objective To assess driving performance and neurocognitive skills of long‐term users of sedating antidepressants, in comparison to healthy controls. Methods Thirty‐eight long‐term (>6 months) users of amitriptyline (n = 13) and mirtazapine (n =
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847246374f35815e46ff6b14e5376e0e
https://cris.maastrichtuniversity.nl/en/publications/4f6aece2-8d1d-4f6a-92f7-364ced3bdf5d
https://cris.maastrichtuniversity.nl/en/publications/4f6aece2-8d1d-4f6a-92f7-364ced3bdf5d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van der Sluiszen, Nick N.J.J.M., Vermeeren, Annemiek, Verster, Joris C., van de Loo, Aurora J.A.E., van Dijken, Joke H., Veldstra, Janet L., Brookhuis, Karel A., de Waard, Dick, Ramaekers, Johannes G., Afd Pharmacology, One Health Toxicologie, dIRAS RA-1, Pharmacology
Publikováno v:
Human Psychopharmacology-Clinical and Experimental, 34(6):e2715. Wiley
Human Psychopharmacology
Human Psychopharmacology, 34(6):e2715. John Wiley and Sons Ltd
Human Psychopharmacology, 34(6). John Wiley and Sons Ltd
Human Psychopharmacology
Human Psychopharmacology, 34(6):e2715. John Wiley and Sons Ltd
Human Psychopharmacology, 34(6). John Wiley and Sons Ltd
OBJECTIVE: The aim of this study is to compare actual driving performance and skills related to driving of patients using benzodiazepine anxiolytics or hypnotics for at least 6 months to that of healthy controls.METHODS: Participants were 44 long-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c7e6b55cccdf61946a112469890e8c6
https://cris.maastrichtuniversity.nl/en/publications/5fac33bc-f663-4fab-a990-bed8a2a09752
https://cris.maastrichtuniversity.nl/en/publications/5fac33bc-f663-4fab-a990-bed8a2a09752
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van der Sluiszen NNJJM; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Vermeeren A; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., van Dijken JH; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., J A E van de Loo A; Division Pharmacology, Utrecht University, Utrecht, The Netherlands.; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands., Veldstra JL; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., de Waard D; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., C Verster J; Division Pharmacology, Utrecht University, Utrecht, The Netherlands.; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia., A Brookhuis K; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., Ramaekers JG; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
Human psychopharmacology [Hum Psychopharmacol] 2021 Jan; Vol. 36 (1), pp. 1-12. Date of Electronic Publication: 2020 Oct 01.
Autor:
van der Sluiszen NNJJM; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Vermeeren A; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Verster JC; Division Pharmacology, Utrecht University, Utrecht, The Netherlands.; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, Victoria, Australia., van de Loo AJAE; Division Pharmacology, Utrecht University, Utrecht, The Netherlands.; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands., van Dijken JH; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., Veldstra JL; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., Brookhuis KA; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., de Waard D; Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands., Ramaekers JG; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
Human psychopharmacology [Hum Psychopharmacol] 2019 Nov; Vol. 34 (6), pp. e2715.